ShanXi C&Y Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 457.827 million compared to CNY 394.615 million a year ago. Operating loss was CNY 1.650 million compared to CNY 84.609 million a year ago. Net loss was CNY 4.118 million compared to CNY 75.229 million a year ago. Basic loss per share from continuing operations was CNY 0.0181 compared to CNY 0.3611 a year ago.